An advanced ultrasound-activated drug delivery system with piezocatalytic MoS2 nanoflowers for treating patent ductus arteriosus
Bibliographic record
Abstract
No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.
Source: Not provided · Quality: missing
Research context
OpenAlex topics: Cardiovascular Conditions and Treatments · Wireless Power Transfer Systems · Cardiac Arrhythmias and Treatments
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (43)
Show source-provided references
1. The ductus arteriosus: physiology, regulation, and functional and congenital anomalies10.1016/j.acvd.2010.06.006 ↗
2. Pulsed Doppler echocardiographic determination of time of ductal closure in normal newborn infants10.1016/S0022-3476(81)80719-6 ↗
3. Patent ductus arteriosus: are current neonatal treatment options better or worse than no treatment at all?10.1053/j.semperi.2011.09.022 ↗
4. Prevalence of spontaneous closure of the ductus arteriosus in neonates at a birth weight of 1000 grams or less10.1542/peds.2005-1528 ↗
5. Review of studies evaluating ductal patency in the premature infant10.1016/S0022-3476(09)90044-0 ↗
6. Decreased plasma glucose after indomethacin therapy in premature infants with patent ductus arteriosus10.1016/S0140-6736(82)91725-1 ↗
7. Prostaglandin E1 infants with ductus arteriosus-dependent congenital heart disease10.1161/01.CIR.64.5.899 ↗
8. Patent ductus arteriosus10.1161/CIRCULATIONAHA.105.592063 ↗
9. PGE2 through the EP4 receptor controls smooth muscle gene expression patterns in the ductus arteriosus critical for remodeling at birth10.1016/j.prostaglandins.2012.02.001 ↗
10. Physical activity, all-cause mortality, and longevity of college alumni10.1056/NEJM198603063141003 ↗
11. Changing trends in the epidemiology and pathogenesis of neonatal chronic lung disease10.1016/S0022-3476(95)70362-4 ↗
12. Inhibition of prostaglandin synthesis in man10.1016/0006-291X(72)90470-6 ↗
13. Comparison of two neonatal indomethacin protocols: efficacy and outcome for patent ductus arteriosus closure10.1111/j.1365-2710.2009.01142.x ↗
14. Increased indomethacin dosing for persistent patent ductus arteriosus in preterm infants: a multicenter, randomized, controlled trial10.1016/j.jpeds.2008.01.031 ↗
15. Comparison of the efficacy and safety of indomethacin, ibuprofen, and paracetamol in the closure of patent ductus arteriosus in preterm neonates – a randomized controlled trial
16. Patent ductus arteriosus and its treatment as risk factors for neonatal and neurodevelopmental morbidity10.1542/peds.2006-3124 ↗
17. Transcatheter closure of patent ductus arteriosus in premature infants with very low birth weight
18. MoS2 nanoflowers as a gateway for solar-driven CO2 photoreduction10.1021/acssuschemeng.8b03168 ↗
19. Defect-engineered atomically thin MoS2 homogeneous electronics for logic inverters10.1002/adma.201906646 ↗
20. Systematic investigation of the piezocatalysis–adsorption duality of polymorphic MoS2 nanoflowers10.1016/j.apcatb.2022.121717 ↗
21. Functionalized ionic liquid exfoliated mos2 nanosheets for photoacoustic imaging guided synergistic photothermal/chemotherapy
22. Photothermal attenuation of cancer cell stemness, chemoresistance, and migration using CD44-targeted MoS2 nanosheets10.1021/acs.nanolett.3c00089 ↗
23. An erythrocyte membrane-camouflaged biomimetic nanoplatform for enhanced chemo-photothermal therapy of breast cancer10.1039/D1TB02522H ↗
24. Antibody-conjugated and streptomycin-chitosan oligosaccharide-modified gold nanoshells for synergistic chemo-photothermal therapy of drug-resistant bacterial infection10.1016/j.jare.2022.08.009 ↗
25. A sequential delivery system based on MoS2 nanoflower doped chitosan/oxidized dextran hydrogels for colon cancer treatment10.1016/j.ijbiomac.2023.123616 ↗
26. Piezoelectricity induced water splitting and formation of hydroxyl radical from active edge sites of MoS2 nanoflowers10.1016/j.nanoen.2018.02.010 ↗
27. Piezoelectric MoS2 Nanoflowers (NF's) for targeted cancer therapy by gelatin-based shear thinning hydrogels. In vitro and In vivo trials10.1016/j.reactfunctpolym.2022.105435 ↗
28. MoS2-based nanocomposites for cancer diagnosis and therapy
29. Selective activation of cells by piezoelectric molybdenum disulfide nanosheets with focused ultrasound10.1021/acsnano.2c12438 ↗
30. Piezoelectric effect in chemical vapour deposition-grown atomic-monolayer triangular molybdenum disulfide piezotronics10.1038/ncomms8430 ↗
31. Enhanced drug loading capacity of 10-hydroxycamptothecin-loaded nanoparticles prepared by two-step nanoprecipitation method10.1016/j.jddst.2016.09.012 ↗
32. Pluronic F127 self-assembled MoS2 nanocomposites as an effective glutathione responsive anticancer drug delivery system10.1039/C9RA04249K ↗
33. A flexible photo-thermoelectric nanogenerator based on MoS2/PU photothermal layer for infrared light harvesting10.1016/j.nanoen.2018.04.072 ↗
34. Piezo-catalytic effect on the enhancement of the ultra-high degradation activity in the dark by single- and few-layers MoS2 nanoflowers10.1002/adma.201505785 ↗
35. NIR photoresponsive drug delivery and synergistic chemo-photothermal therapy by monodispersed-MoS2-nanosheets wrapped periodic mesoporous organosilicas10.1039/C6TB02724E ↗
36. Randomized trial of prolonged low-dose versus conventional-dose indomethacin for treating patent ductus arteriosus in very low birth weight infants10.1542/peds.112.2.345 ↗
37. Interventions for patent ductus arteriosus (PDA) in preterm infants: an overview of Cochrane Systematic Reviews
38. Impact of early screening echocardiography and targeted PDA treatment on neonatal outcomes in “22-23” week and “24-26” infants10.1016/j.semperi.2023.151721 ↗
39. High intensity focused ultrasound: the fundamentals, clinical applications and research trends10.1016/j.diii.2018.03.001 ↗
40. Sports Ultrasound", advantages, indications and limitations in upper and lower limbs musculoskeletal disorders. Review article10.1016/j.ijsu.2017.11.034 ↗
41. Ultrasound-guided drug delivery system utilizing piezocatalytic MoS2 nanomaterials for anti-inflammatory therapy10.1016/j.nanoen.2024.109732 ↗
42. Piezoelectric and triboelectric nanogenerators: promising technologies for self-powered implantable biomedical devices
43. Robotics, microfluidics, nanotechnology and AI in the synthesis and evaluation of liposomes and polymeric drug delivery systems10.1007/s13346-021-00929-2 ↗